An update on obsessive-compulsive disorder.
暂无分享,去创建一个
[1] D. Black. Obsessive-Compulsive Disorders: Practical Management, 3rd ed. , 2001 .
[2] M. Weissman,et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. , 1994, The Journal of clinical psychiatry.
[3] Lee Baer,et al. Obsessive-Compulsive Disorders: Practical Management , 1998 .
[4] M. Jenike,et al. Coexistent obsessive-compulsive disorder and schizotypal personality disorder: a poor prognostic indicator. , 1986, Archives of general psychiatry.
[5] J H Greist,et al. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. , 1995, Archives of general psychiatry.
[6] S. Freud. The Standard Edition of the Complete Psychological Works of Sigmund Freud , 1953 .
[7] M. Jenike,et al. Stereotactic radiofrequency thermal cingulotomy for obsessive compulsive disorder. , 1961, The Journal of neuropsychiatry and clinical neurosciences.
[8] T. Insel,et al. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. , 1983, Archives of general psychiatry.
[9] Dc Washington. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .
[10] E. Moniz. PREFRONTAL LEUCOTOMY IN THE TREATMENT OF MENTAL DISORDERS , 1937 .
[11] E. Foa,et al. Differential effects of exposure and response prevention in obsessive-compulsive washers. , 1980, Journal of consulting and clinical psychology.
[12] B. Leventhal,et al. Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder. , 2002, Journal of child and adolescent psychopharmacology.
[13] C. McDougle,et al. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. , 1995, The Journal of clinical psychiatry.
[14] D. Black. Obsessive-Compulsive Disorders: Theory and Management, 2nd ed , 1991 .
[15] J. Leckman,et al. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. , 1986, The New England journal of medicine.
[16] M. Jann,et al. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. , 1992, Clinical pharmacy.
[17] M. Jenike,et al. An open trial of buspirone in obsessive-compulsive disorder. , 1988, The American journal of psychiatry.
[18] S. Rauch,et al. Neurobiological models of obsessive-compulsive disorder. , 1993, Psychosomatics.
[19] C. McDougle,et al. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. , 1991, Journal of clinical psychopharmacology.
[20] M. Jenike,et al. Obsessive-Compulsive Disorders: Theory and Management , 1986 .
[21] M. Drake. Diagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.) , 1988 .
[22] E. Foa. Failure in treating obsessive-compulsives. , 1979, Behaviour research and therapy.
[23] M. Jenike,et al. Monoamine oxidase inhibitors in obsessive-compulsive disorder. , 1983, The Journal of clinical psychiatry.
[24] Young Cr,et al. Clozapine and refractory obsessive-compulsive disorder: a case report. , 1994 .
[25] T. Insel,et al. Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder , 1989, British Journal of Psychiatry.
[26] C. McDougle,et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior , 1994, Psychoneuroendocrinology.
[27] D. Murphy,et al. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder. , 1998, The Journal of clinical psychiatry.
[28] A. McIntyre,et al. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder , 1993, European Neuropsychopharmacology.
[29] C. Gonsalvez,et al. Response inhibition deficits in obsessive–compulsive disorder , 2002, Psychiatry Research.
[30] M. Jenike. Augmentation Strategies for Treatment‐Resistant Obsessive‐Compulsive Disorder* , 1993, Harvard review of psychiatry.
[31] Rapoport Jl,et al. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. , 1988 .
[32] S. Hyman,et al. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. , 1990, The American journal of psychiatry.
[33] Harold I. Kaplan,et al. Comprehensive textbook of psychiatry/III , 1980 .
[34] THEODOREP. Zahn,et al. Treatment of Patients with Obsessive Compulsive Disorder , 2006 .
[35] M. Jenike,et al. Standardized assessment of personality disorders in obsessive-compulsive disorder. , 1990, Archives of general psychiatry.
[36] N. Alpert,et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. , 1994, Archives of general psychiatry.
[37] D. Murphy,et al. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. , 1991, The American journal of psychiatry.
[38] C. McDougle,et al. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. , 1990, The American journal of psychiatry.
[39] D. Murphy,et al. A Controlled Comparison of Adjuvant Lithium Carbonate or Thyroid Hormone in Clomipramine‐Treated Patients with Obsessive‐Compulsive Disorder , 1991, Journal of clinical psychopharmacology.
[40] J. Rapoport,et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. , 1997, The American journal of psychiatry.
[41] A. Bulbena,et al. Clomipramine versus Phenelzine in Obsessive–Compulsive Disorder , 1992, British Journal of Psychiatry.
[42] R. Michels,et al. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed , 1981 .
[43] S. Sorenson,et al. The epidemiology of obsessive-compulsive disorder in five US communities. , 1988, Archives of general psychiatry.
[44] C. McDougle,et al. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. , 1994, Archives of general psychiatry.
[45] C. McDougle,et al. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. , 1995, The American journal of psychiatry.
[46] M. Jenike. Neurosurgical treatment of obsessive-compulsive disorder , 1998, British Journal of Psychiatry.
[47] M. Jenike,et al. Obsessive-compulsive and related disorders. , 2020, Handbook of clinical neurology.
[48] M. Jenike. Obsessive-compulsive disorder: efficacy of specific treatments as assessed by controlled trials. , 1993, Psychopharmacology bulletin.
[49] M. Jenike,et al. Age of onset of major subtypes of obsessive—compulsive disorder , 1990 .
[50] G. Maina,et al. Predictors of drug treatment response in obsessive-compulsive disorder. , 1995, The Journal of clinical psychiatry.
[51] M. Jenike,et al. Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. , 1991, Archives of general psychiatry.
[52] J. Mazziotta,et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. , 1988, The American journal of psychiatry.
[53] W. Agras,et al. Clomipramine, Clonazepam, and Clonidine Treatment of Obsessive‐Compulsive Disorder , 1992, Journal of clinical psychopharmacology.
[54] M. Jenike,et al. Drs. Jenike and Baer Reply , 1988 .
[55] T. Insel,et al. Toward a neuroanatomy of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.
[56] Laporta Ld. More on obsessive-compulsive symptoms and clozapine. , 1994 .
[57] D. C. Olivier,et al. Prodromes of Depression and Anxiety , 1989, British Journal of Psychiatry.
[58] C. McDougle,et al. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. , 1992, The Journal of clinical psychiatry.
[59] M E Phelps,et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.
[60] D. Murphy,et al. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. , 1993, The American journal of psychiatry.
[61] I. Marks. Review of behavioral psychotherapy, I: Obsessive-compulsive disorders. , 1981, The American journal of psychiatry.
[62] J. Mazziotta,et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. , 1992, Archives of general psychiatry.